Loading...
Market
Which medication will be the most popular on PfizerForAll by December 31, 2024?
2
Resolution / Starting Odds
Migraine medication • 25%
COVID-19 medication • 25%
Flu medication • 25%
Respiratory illness medication • 25%
Sales data from Pfizer's official reports
Story
PfizerForAll: Pfizer Launches Telehealth Platform for Direct Medication Sales
Aug 27, 2024, 12:13 PM
Pfizer has launched a new digital platform, PfizerForAll™, aimed at simplifying access to healthcare by selling medications directly to consumers. This initiative is part of Pfizer's strategy to address declining demand for its COVID-19 products and follows a similar move by Eli Lilly earlier this year. The platform will offer products for conditions such as migraines, COVID-19, flu, and respiratory illnesses, integrating services like diagnosis, prescribing, telehealth, and vaccine scheduling. Key partners, including Alto Pharmacy, are involved in this direct-to-consumer model, which highlights a growing trend in the pharmaceutical industry towards telehealth and online prescription services.
View original story
Similar markets
Diagnosis • 25%
Prescribing • 25%
Vaccine scheduling • 25%
Prescription fulfillment • 25%
Covid vaccine • 25%
Paxlovid • 25%
Other Pharmaceutical Product • 25%
Other Vaccine • 25%
Paxlovid • 25%
Comirnaty • 25%
Prevnar • 25%
Other • 25%
Cancer drugs • 25%
COVID-19 treatment • 25%
Vaccines • 25%
Other pharmaceuticals • 25%
Yes • 50%
No • 50%
None • 25%
1 new category • 25%
2 to 3 new categories • 25%
More than 3 new categories • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
Biotech company • 25%
Pharmaceutical company • 25%
Medical device company • 25%
Other • 25%
Mounjaro • 25%
Zepbound • 25%
Trulicity • 25%
Other • 25%
Outperforms all • 25%
Outperforms some • 25%
Matches performance • 25%
Underperforms all • 25%
Novavax • 25%
Moderna • 25%
Pfizer • 25%
Other • 25%